biote Corp. (BTMD) — Stock Score Summary

biote Corp. (BTMD) has a MoatMap StockRank of 61/100 based on Quality (58/100), Value (63/100), and Momentum (25/100) factor scores. The current signal is HOLD. biote Corp is a micro-cap hormone therapy provider that lacks the scale, regulatory moat, or global distribution to fit our high-conviction portfolio.

biote Corp. is a healthcare company specializing in preventive medicine and hormone optimization therapies through its proprietary training, software, and pellet products. The company's competitive moat is its extensive network of trained, certified practitioners and a highly scalable, recurring-revenue business model. Biote operates as a market leader in the specialized field of bioidentical hormone replacement therapy.

Key Financial Metrics

Price$2.21
Market Cap$73M
P/E (TTM)5.49
P/E (Forward)4.14
Price/Book-1.26
Return on Invested Capital77.5%
Gross Margin70.1%
Operating Margin9.8%
Revenue Growth-8.3%
Free Cash Flow$-5M

biote Corp. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is biote Corp.’s (BTMD) StockRank?
MoatMap’s StockRank for biote Corp. (BTMD) is 61/100, with a Hold signal. It is a composite of Quality (58), Value (63), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does biote Corp. have an economic moat?
biote Corp. (BTMD) has a Quality factor score of 58/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is biote Corp. a buy, hold, or sell?
MoatMap’s current signal for biote Corp. (BTMD) is Hold, based on a StockRank of 61/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is biote Corp. in?
biote Corp. (BTMD) operates in the Healthcare sector, specifically the Medical Care Facilities industry (United States).